305 related articles for article (PubMed ID: 25509368)
21. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
[TBL] [Abstract][Full Text] [Related]
22. [Autoantibodies against GAD and GAD65].
Tsujii S
Nihon Rinsho; 1998 Jan; 56 Suppl 3():190-5. PubMed ID: 9513413
[No Abstract] [Full Text] [Related]
23. Apraxia in anti-glutamic acid decarboxylase-associated stiff person syndrome: link to corticobasal degeneration?
Bowen LN; Subramony SH; Heilman KM
Ann Neurol; 2015 Jan; 77(1):173-6. PubMed ID: 25100431
[TBL] [Abstract][Full Text] [Related]
24. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
[TBL] [Abstract][Full Text] [Related]
25. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
[No Abstract] [Full Text] [Related]
26. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.
Dalakas MC; Li M; Fujii M; Jacobowitz DM
Neurology; 2001 Sep; 57(5):780-4. PubMed ID: 11552003
[TBL] [Abstract][Full Text] [Related]
27. Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab.
Bacorro EA; Tehrani R
J Clin Rheumatol; 2010 Aug; 16(5):237-9. PubMed ID: 20577094
[TBL] [Abstract][Full Text] [Related]
28. [Stiff-man syndrome from the perspective of internal medicine and immunology].
Seissler J; Scherbaum WA
Internist (Berl); 2000 May; 41(5):460-6. PubMed ID: 10867902
[No Abstract] [Full Text] [Related]
29. GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.
Solimena M; Butler MH; De Camilli P
J Endocrinol Invest; 1994; 17(7):509-20. PubMed ID: 7829825
[No Abstract] [Full Text] [Related]
30. Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum.
Pfützner A; Forst T; Ambrosch A; Schmitz H; Lichtwald K; Beyer J
Exp Clin Endocrinol Diabetes; 1995; 103(2):123-5. PubMed ID: 7553076
[TBL] [Abstract][Full Text] [Related]
31. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome.
Jarius S; Stich O; Speck J; Rasiah Ch; Wildemann B; Meinck HM; Rauer S
J Neuroimmunol; 2010 Dec; 229(1-2):219-24. PubMed ID: 20813415
[TBL] [Abstract][Full Text] [Related]
32. Stiff, twitchy or wobbly: are GAD antibodies pathogenic?
Vincent A
Brain; 2008 Oct; 131(Pt 10):2536-7. PubMed ID: 18799517
[No Abstract] [Full Text] [Related]
33. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
[TBL] [Abstract][Full Text] [Related]
34. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
35. Islet cell antibodies: variable immunostaining of pancreatic islet cells and carcinoid tissue.
Hallberg A; Juhlin C; Berne C; Kämpe O; Karlsson FA
J Intern Med; 1995 Sep; 238(3):207-13. PubMed ID: 7673849
[TBL] [Abstract][Full Text] [Related]
36. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
[TBL] [Abstract][Full Text] [Related]
37. Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?
Lacruz Ballester L; Fernandez-Fournier M; Puertas Muñoz I; Rodriguez Fraga O; Lastras Fernandez-Escandon C; Rodriguez de Rivera Garrido FJ; Alba Suarez EM; Tallon Barranco A
Neurol Sci; 2022 Jan; 43(1):633-641. PubMed ID: 33914193
[TBL] [Abstract][Full Text] [Related]
38. Anti-glutamic acid decarboxylase antibody positive neurological syndromes.
Tohid H
Neurosciences (Riyadh); 2016 Jul; 21(3):215-22. PubMed ID: 27356651
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.
Solimena M; Folli F; Denis-Donini S; Comi GC; Pozza G; De Camilli P; Vicari AM
N Engl J Med; 1988 Apr; 318(16):1012-20. PubMed ID: 3281011
[TBL] [Abstract][Full Text] [Related]
40. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders.
Alexopoulos H; Akrivou S; Dalakas MC
Neurology; 2013 Nov; 81(22):1962-4. PubMed ID: 24174585
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
